Capricor Therapeutics CAPR Business Segments — General And Administrative Expense

Similar metrics at other companies

ALMSSingle Reportable — General And Administrative Expense

$18.61M-16.5%

ACLSSingle Reportable — General And Administrative Expense

$26.76M+54.2%

VERXSingle Reportable — General And Administrative Expense

$54.34M+20.7%

MMSISingle Reportable — General And Administrative Expense

$44.25M+4.0%

IOVASingle Reportable — General And Administrative Expense

$18.7M-5.8%

IMNMSingle Reportable — General And Administrative Expense

-$8.65M-17.3%

Questions, answered.

What is Capricor Therapeutics's business segments — general and administrative expense?

Capricor Therapeutics (CAPR) reported business segments — general and administrative expense of $9.4M in Q1 2026.

How has Capricor Therapeutics's business segments — general and administrative expense changed year-over-year?

Capricor Therapeutics's business segments — general and administrative expense increased by 54.9% year-over-year, from $6.07M to $9.4M.

What does business segments — general and administrative expense mean?

This metric represents the total aggregate costs incurred for the administrative, legal, and corporate support functions of the business segment. It serves as a measure of the overhead required to manage the company's operations and regulatory compliance. Controlling these expenses is vital for preserving capital in early-stage biotechnology companies.